Research interests include Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Brain Metastases and Treatment, and Immunotherapy and Immune Responses.
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
The Lancet Oncology2017cited by 1,105position: middledoi
Phase III randomized study of radiation and temozolomide versus radiation and nitrosourea therapy for anaplastic astrocytoma: results of NRG Oncology RTOG 9813